Clinical and pathological dermatological features of deficiency of adenosine deaminase 2: A multicenter, retrospective, observational study - 09/11/20
, Antoine Fayand, MD b, Philippe Moguelet, MD c, Floriane Kouby, MD a, Axelle Bonhomme, MD d, Nathalie Franck, MD e, Gabrielle Goldman-lévy, MD f, Sylvie Fraitag, MD g, Annick Barbaud, MD, PhD a, Viviane Queyrel, MD h, Isabelle Touitou, MD, PhD i, Guilaine Boursier, PharmD, PhD i, Guillaume Sarrabay, MD i, Stéphanie Ducharme-Benard, MD b, j, Nicolas Dupin, MD, PhD e, Camille Francès, MD a, Didier Bessis, MD, PhD k, Sophie Georgin-Lavialle, MD, PhD bGroupe d'étude des maladies systémiques en dermatologie and Centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire
| Drs Chasset and Fayand are cofirst authors. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
Vol 83 - N° 6
P. 1794-1798 - dicembre 2020 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
